TRPM8 has also been found to be overexpressed in many tumors, including prostate, breast, colorectal, and pancreatic cancers, amongst others (5), suggesting that TRPM8 may have potential as a marker and drug target for cancer management. This evidence concerns the gene TRPM8 and familial pancreatic carcinoma.